21 Sep 2009 14:41
21 September 2009
Amphion Innovations plc
(the "Company")
Directors' dealing
Directors Receive Shares in Lieu of Fees
Amphion Innovations plc (LSE: AMP), the developer of medical and technology businesses, today announces that the Company has issued 273,976 ordinary shares (the "New Shares"), representing 0.21% of the enlarged issued share capital, to certain of its Board members, in lieu of their directors' fees to June 2009, at 13.05p, being the average of the closing mid-market price for the five business days from the end of the close period to 27 August 2009.
Following this issue, the directors' shareholdings in the Company are as follows:
| Director | Number of New Shares | Subsequent aggregate beneficial interest | Percentage of voting rights |
| Richard Mansell-Jones | 81,510 | 3,048,617 | 2.31% |
| Anthony Henfrey | 62,500 | 1,128,235 | 0.86% |
| R. James Macaleer | 79,966 | 22,444,114 | 17.01% |
| Gerard Moufflet | 50,000 | 50,000 | 0.04% |
The New Shares will rank pari passu with the existing ordinary shares of the Company. Application has been made for the New Shares to trading on AIM which is expected to commence on 24 September 2009. Upon issue of the New Shares, the Company will have 131,956,036 ordinary shares in issue each share holding one voting right.
For further information please contact:
Amphion Innovations plc Charlie Morgan, Director of Communications +1 (212) 210 6224
Cardew Group Tim Robertson/ Jamie Milton/ Matthew Law +44 20 7930 0777
Charles Stanley (Nominated Adviser) Freddy Crossley/ Jen Boorer +44 20 7149 6000